Page 5 - முன்னேற்றங்கள் பார்மா அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Strides, TLC partner to launch black fungus drug in India PTI Updated May 27, 2021, 3:13 pm IST AmphoTLC will be imported from Taiwan by Stelis Biopharma Pvt Ltd  The Central Drugs Standard Control Organization (CDSCO) has approved TLC s new drug application. (Photo: PTI) New Delhi: Strides Pharma Science and Taiwan-based specialty pharmaceutical firm TLC have partnered to launch Liposomal Amphotericin B, a drug used in the treatment of mucormycosis (black fungus), in India. The Central Drugs Standard Control Organization (CDSCO) has approved TLC s new drug application (NDA) of Amphotericin B Liposome for Injection 50mg in India for immediate importation per approved usage and indication, Strides and TLC said in a joint statement on Thursday.

New delhiGeorge yehStelis biopharma pvt ltdCentral drugs standard control organizationStrides pharma scienceAmphotericinb liposomeCovid vaccineNew covid vaccineCovid vaccinationEw covid vaccinationபுதியது டெல்ஹிஜார்ஜ் ஆமாம்மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்முன்னேற்றங்கள் பார்மா அறிவியல்